- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Berlin, Humboldt-Universität zu Berlin, Dissertation, 2024
- Schlagwort
-
Neuroblastom
- Ereignis
-
Veröffentlichung
- (wo)
-
Berlin
- (wer)
-
Humboldt-Universität zu Berlin
- (wann)
-
2024
- Urheber
- Beteiligte Personen und Organisationen
-
Henssen, Anton
Landthaler, Markus
Corbacioglu, Selim
- DOI
-
10.18452/29113
- URN
-
urn:nbn:de:kobv:11-110-18452/29823-9
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bei, Yi
- Henssen, Anton
- Landthaler, Markus
- Corbacioglu, Selim
- Humboldt-Universität zu Berlin
Entstanden
- 2024
Ähnliche Objekte (12)
Collateral amplification under complete markets
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Blinding the CYCLOPS - neuroblastoma vulnerabilities unveiled by 1p loss
Blinding the CYCLOPS - Neuroblastoma vulnerabilities unveiled by 1p loss
On the amplification role of collateral constraints
Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
5′ ALK Amplification in Neuroblastoma: A Case Report
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma
Collateral amplification under complete markets
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Blinding the CYCLOPS - neuroblastoma vulnerabilities unveiled by 1p loss
Blinding the CYCLOPS - Neuroblastoma vulnerabilities unveiled by 1p loss
On the amplification role of collateral constraints
Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
5′ ALK Amplification in Neuroblastoma: A Case Report
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling
FGFR inhibition blocks NF-ĸB-dependent glucose metabolism and confers metabolic vulnerabilities in cholangiocarcinoma
Collateral amplification under complete markets
Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells
Blinding the CYCLOPS - neuroblastoma vulnerabilities unveiled by 1p loss
Blinding the CYCLOPS - Neuroblastoma vulnerabilities unveiled by 1p loss
On the amplification role of collateral constraints
Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response
5′ ALK Amplification in Neuroblastoma: A Case Report
N-Myc-induced metabolic rewiring creates novel therapeutic vulnerabilities in neuroblastoma
Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer
Multi-Parametric Drug Screening identifies Vulnerabilities and Combination Treatment Strategies for Neuroblastoma Subtypes
MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling